Blockchain
4th Annual Digi-Tech Pharma & AI Conference, 2020 (London, United Kingdom – May 13-14, 2020)
Dublin, Feb. 12, 2020 (GLOBE NEWSWIRE) — The “Digi-Tech Pharma & AI 2020” conference has been added to ResearchAndMarkets.com’s offering.
The 4th Annual Digi-Tech Pharma & AI conference brings with it even more interactive sessions, expert speakers, senior professionals and decision-makers from leading pharma, biotech and healthcare industry.
Meet the decision-makers, benchmark and learn from real-life use cases to drive organizational change and to understand the new cutting-edge technologies and practical solutions.
In this 4th edition, as we explore the novel technologies and developments reforming the pharmaceutical industry, we also dive deep into the implementation and advances in machine learning, deep learning, artificial intelligence, informatics and data science which has redefined the development of new drugs, tackle diseases, improving healthcare and much more.
The enhancements in data management and data integration are providing improvements to both the speed and quality of drug discovery and many clinical trial processes. To be in the forefront, a necessity for partnership and collaboration with healthcare provider is a must for the pharmaceutical companies, and these partnerships will also lead to massive advances in R&D using artificial intelligence in genomics and precision medicine to develop a deep understanding of the root causes of diseases.
The combination of AI, big data and IoT technologies are creating new innovations, also other eminent technologies like cloud computing, augmented reality, virtual reality and blockchain are being used extensively in the Pharmaceutical industry’s digital transformation.
It gives us a great pleasure to welcoming you to this international pharmaceutical technology conference 4th Annual Digi-Tech Pharma & AI 2020.
Key Highlights
Reimagining Pharma by Integrating Science and Technology
- Digital Technology trends in Pharma and Bio-Tech industry
- Adopting AI and Machine Learning to unlock the full potential of Pharma
- How pharma can integrate into the digital health environment
- Collaborative Innovation: Finding the right partners to leverage new technologies in Pharma
- Patient Centred Drug Discovery
Digital Discovery and Clinical Trials
- Applying AI to the design of lead compounds for new drugs
- Algorithms and Models for drug discovery
- AI and ML for Target Identification & Validation in Drug Discovery
- Advancing Drug Discovery through quantum computing
- Genomics & Drug Discovery
- Virtual and Hybrid Clinical Trials
- R&D Use Cases
Decoding the Value of Data Science, Big Data & Informatics
- Implementation and relevance of FAIR data principles in Pharma R&D
- Harnessing Data Science for Drug Combination Discovery
- AI and Big Data: A powerful combination for future growth
- The use of AI to make sense of clinical data
- Use of big data for precision medicine
- Multi-omics & clinical data to unlock the power of complex datasets
- Integration and Visualization of translational Medicine Data
- Data & Healthcare Analytics
Real-World Data & Real-World Evidence
- The Growing Importance of Real-World Data
- RWD for clinical research and drug development
- RWE and RWD to support regulatory decision making
- RealWorld Data Science to advance Patient Care
- Managing real-world data governance
Digital Health & Future Innovations
- Healthcare & Medical Technology
- Adoption of IoT in Pharma
- Potential of Cloud Computing in Pharma
- Impact of Digital Health in Pharma
- Digital Health strategy and Patient-centric Clinical Trials
- The convergence of Digital Therapeutics and Pharma in Digital Health
- How pharma-health collaboration works on innovating drug discovery & patient experience
- Blockchain and AI-based Platform
Agenda
Day 1
08:15 – Registration & Refreshments
08:50 – Chairperson’s opening remarks
Digital Transformation & Pharma
09:00 – Accelerating Digital Transformation in Pharma
- Company leadership and transformation
- Need for communication specialists and up-to-date technologies
- Hiring digital experts and collaborations
- The need to be really quick in transforming at every level
09:30 – Executives Discussion and Debate: Adopting AI and Machine Learning to unlock the full potential of Big Pharma
- Innovation in Big-Pharma
- AI-enabled business models in R&D
- Achieving full potential of AI to boost Drug Discovery and Development
- AI has the capacity to radically reduce the uncertainty in both early and late-stage drug discovery and development
10:00 – Collaborative Innovation: Finding the right partners to leverage new technologies in Pharma
- How early-stage partnering and collaboration will inhibit pharma innovation
- How Biotech revolution has changed the face of drug development?
- Working with incubators, accelerators and innovation forums can also help
- Having a good governance structure in place
10:30 – Morning Coffee/Tea & Networking
AI-ML, Digital Discovery and Clinical Trials
10:50 – Advancing Drug Discovery via Artificial Intelligence
11:20 – Cutting-edge Computational Modelling and Deep Learning in Drug Discovery
11:50 – Maximizing Drug Discovery Success with Machine Learning
- Using machine learning to integrate distinct, bigger datasets created from high throughput screening data can provide a path to predict bioactivities for targets and molecular properties with increased levels of accuracy
- Broader applicability of machine learning and the potential to change the drug development paradigm
- ML tools that can improve discovery and decision making
12:20 – Networking & Luncheon
13:00 – Combining robotics and AI for data-driven drug discovery
Genomics and Precision Medicine
13:30 – Enabling precision medicine with integrated genomic and clinical data
- Transforming the entire pharmaceutical value chain
- How do we implement Precision Medicine in the Real World?
- How does it affect the ecosystem of healthcare?
- Future of genomics and precision medicine
14:00 – Powering Precision Medicine with Artificial Intelligence – AI to further advance drug combination design and development of precision medicine
Data Science, Big Data & Informatics
14:30 – Implementation and relevance of FAIR data principles in Pharmaceutical R&D
- Improving the efficiency and effectiveness by implementing the FAIR guiding principles for scientific data
- Tools enabling FAIR data
- Fair as a machine learning enabler
- Benefits of FAIR in pharma
15:00 – Afternoon Networking Tea Break
15:20 – Big data & AI in Pharma: How Data, AI and externalisation strategy impacts Drug Discovery
- Importance of big data in decision making
- Predominantly with pipelines paying attention on treatments for rare diseases
- Need for data integration and collaborations for free flow of information
- Getting big data ready for AI
15:50 – Integration and Visualization of translational Medicine Data
16:20 – Case Study on Data and Patient Engagement: PsoHappy: Tactics to Massively Scale Patient Engagement
- Why we need to rethink how we measure the quality of life when we engage patients
- Scaling up Data – How LEO Innovation Lab engaged over 200,000 psoriasis patients across 184 countries
- Impact update: supporting IFPA and national patient associations to ensure insights can be utilized in supporting advocacy efforts
- Pitfalls of current health-related quality measures we employ in clinical trials
16:50 – Round Table Discussion:
- All the participants will have a great opportunity to discuss and explore a selection of the most interesting topics discussed during the conference in small groups with their industry colleagues in an informal setting.
- Each table will nominate a head who will summarise the discussion and questions posed. The group members are given equal rights to share and learn from each other’s experiences to discover an actionable solution on the discussed topic.
17:20 – Chairperson’s closing remarks
17:30 – Networking Drinks Session
Day 2
08:15 – Registration & Morning Coffee
08:50 – Chairperson’s opening remarks
Real-World Data & Real World Evidence
09:00 – Real World Evidence model for assessing new drugs – Enhancing Real World Data Environment
- How RWE model can be used in R&D to accelerate new product developments?
- Integrated evidence development model
- Building an effective RWE based capabilities system
- Advantages of implementing AI and ML
09:30 – Integration and Analysis of Real-World Data (RWD) for clinical research and drug development
- Leveraging Real-World Data to Overcome the Inefficiencies of Drug Development
- Understanding the clinical processes
- RWD to create novel, faster and less invasive approaches to advance disease understanding and biomarker discovery
- RWD for EHRs in last phase research studies
- Real-World Data in the clinical study through a decentralized approach
10:00 – Real-World Data Science to Advance Patient Care
10:30 – Morning Coffee/Tea & Networking
10:50 – RWE and RWD to support evidence generation for regulatory approval and market access
Data Visualization, IoT and Cloud
11:20 – How Pharma can leverage Cloud Computing and AI to increase access to the broadest range of data in Drug Discovery and Design?
- BI & Analytics in cloud
- Decentralized IT infrastructure
- Scalability and flexibility
- How can efficiency be improved?
11:50 – Data Visualization Innovations in Life Sciences and Drug Discovery – AI, VR and MR to Support Drug Discovery
12:20 – Networking & Luncheon
13:00 – Adoption of IoT in Pharma
- Potential benefits of the IoT on clinical research
- Data processing and management
- Patient safety and automated monitoring systems
- Challenges in regulatory approval and compliance
Digital Health in Pharma & Future Innovation
13:30 – Potential impact of Digital Health in Pharma
- Strategies for efficient collaboration
- Digital health is proving to be a valuable asset for the pharma industry
- The intersection of health-care and pharma are together transforming the customer journey
- Identifying other areas that need to be looked at
- Innovation is key to the future
14:00 – Digital Innovation and Predictive Technology in Respiratory Medicine
14:30 – Blockchain technology to improve efficiency and safety
15:00 – Afternoon Networking Tea Break
15:50 – The convergence of Digital Therapeutics and Pharma in Digital Health
- Pharma-digital therapeutic alliances
- Making treatment more accessible
- How to fit it into the pharmaceutical workflow
16:20 – Panel Discussion: Emerging technologies and how pharma-health collaboration works on innovating drug discovery & patient experience
- The changing patient behaviour in the digital era
- Why is it essential to be prompt in identifying and addressing the patient’s needs?
- How will digitization help bring patients on board?
- Progress made by companies so far
- Strategies to be adopted to increase patient -company data flow
- Emergence of wearable tech-potential benefits
16:50 – Chairperson’s Closing Remarks and End of the Conference
For more information about this conference visit https://www.researchandmarkets.com/r/p0dgkq
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Blockchain
Blocks & Headlines: Today in Blockchain – May 7, 2025 | Coinbase, Riot Games, Curve DAO, Litecoin, AR.IO
Today’s blockchain and cryptocurrency landscape is as dynamic as ever, with marquee partnerships, industry-wide reckonings, and groundbreaking applications reshaping how we think about digital assets. In this op-ed style daily briefing, we explore five major developments from May 6 – 7, 2025:
-
Coinbase & Riot Games Forge Esports Alliance
-
“Too Many Blockchains?” Industry Introspection
-
Blockchain’s Health-Tech Revolution
-
Valour Adds Curve DAO & Litecoin ETPs in the Nordics
-
AR.IO Enables Credit-Card Onramps for Web3 Identity & Hosting
Through concise yet detailed coverage, we analyze each story’s implications for blockchain, cryptocurrency, Web3, DeFi, and NFTs. Welcome to your Blocks & Headlines daily briefing—where opinion meets analysis.
1. Coinbase & Riot Games Forge Esports Alliance
Source: Coinbase Blog
Date: May 6, 2025
In a landmark partnership that bridges digital finance with digital competition, Coinbase has been named the exclusive cryptocurrency exchange and official blockchain technology partner of Riot Games’ global League of Legends and VALORANT esports events. Starting with the VCT Masters tournament in Toronto on June 7, Coinbase will integrate “live Econ Reports” and “Gold Grind” segments into broadcasts, offering running analyses of in-game currency flows, alongside exclusive digital drops like emotes and icons redeemable by viewers.
Opinion: This move is a masterstroke for mainstream crypto adoption. Esports’ digitally native fanbase aligns perfectly with blockchain’s ethos of transparency and community governance. Coinbase’s embrace of in-game analytics not only educates viewers on micro-economies but also paves the way for future on-chain game mechanics—potentially unlocking true digital ownership of skins and items as NFTs. Expect other exchanges to follow suit or risk missing out on Gen Z’s next frontier of fandom.
2. “Too Many Blockchains?” Industry Introspection
Source: Blockworks
Date: May 6, 2025
As venture capital floods yet another dozen Layer-1 protocols each quarter, seasoned observers are questioning sustainability. Donovan Choy of Blockworks highlights that new chains like Camp Network, Unto, and Miden collectively raised north of $70 million in the past week alone—despite Sui’s market-cap spike lacking any commensurate fee revenue. While some attribute this proliferation to speculative greed chasing the elusive L1 premium, others credit genuine technical divergence—differing visions on execution environments, MEV capture, and data-availability layers.
Opinion: The free market appears to be self-correcting: L1 valuations are compressing, and public markets are already signaling fatigue. Yet, technical fragmentation has its merits—competition drives innovation in consensus, sharding, and gas-fee economics. The looming challenge is application-chain misalignment: developers face choice paralysis and liquidity fragmentation. A pivot toward cross-chain composability—and perhaps the rise of federated execution environments—will determine which chains survive the next cycle. Investors should look for interoperability roadmaps rather than mere tokenomics hype.
3. Blockchain’s Health-Tech Revolution
Source: DataHorizzon Research via OpenPR
Date: May 7, 2025
Blockchain in healthcare is projected to surge from a $4.57 billion market in 2023 to $34.7 billion by 2033 (CAGR 22.9%). Key drivers include:
-
Data Integrity & Security: Immutable ledgers ensure tamper-proof electronic health records, bolstering HIPAA and GDPR compliance.
-
Interoperability: Permissioned smart contracts automate cross-institutional data access, alleviating EHR fragmentation.
-
Supply-Chain Traceability: Real-time drug tracking combats counterfeits and streamlines recalls.
-
Claims Automation: Shared ledgers reduce fraud and billing lags via automated smart-contract adjudication.
-
Research Collaboration: Timestamped trial data and consent forms create verifiable audit trails.
Leading players—IBM Watson Health, Guardtime, Longenesis, Chronicled, BurstIQ, and more—are moving beyond pilots in Estonia and Merck’s vaccine cold-chain projects toward enterprise-scale rollouts.
Opinion: Healthcare’s conservative nature makes blockchain’s strides here particularly noteworthy. The confluence of AI analytics with secure datasets promises predictive diagnostics powered by immutable provenance. Yet, regulatory uncertainty and integration with legacy EHR platforms remain significant hurdles. The winners will be those who offer turnkey compliance frameworks and hybrid on-chain/off-chain models that respect “right to be forgotten” laws while preserving auditability.
4. Valour Adds Curve DAO & Litecoin ETPs in the Nordics
Source: GlobeNewswire (via GlobeNewswire and CoinCentral)
Date: May 7, 2025
DeFi Technologies’ subsidiary Valour has listed single-asset SEK-denominated ETPs for Curve DAO (CRV) and Litecoin (LTC) on Sweden’s Spotlight Stock Market—bringing its Nordic ETP lineup to over 67 products on the path to 100 by year-end. Upcoming listings include Tron (TRX), Stellar (XLM), and leveraged Bitcoin (BTC 2×) and Ethereum (ETH 2×) products.
Opinion: ETPs bridge traditional capital markets with on-chain assets, offering regulated wrappers for institutional and retail investors. Valour’s Nordic expansion underscores Europe’s leadership in crypto security tokenization. However, as ETP count balloons, product fatigue may set in. Success lies not in sheer quantity but in thematic curation and transparent fee structures—particularly for DeFi-native tokens like CRV, where governance risk and protocol upgrades can materially impact value.
5. AR.IO Enables Credit-Card Onramps for Web3 Identity & Hosting
Source: Chainwire (as published by MENAFN)
Date: May 6, 2025
AR.IO—the world’s first permanent cloud network built on Arweave—has launched “Turbo,” an open-source bundler that lets users purchase Arweave credits via credit card for its ArNS domain‐name and web-hosting service. ArNS domains are immutable smart contracts on Arweave, offering permanent websites and on-chain identities without renewal fees, served by 400+ decentralized gateways.
Opinion: Simplifying fiat → crypto onramps remains a critical barrier for mainstream Web3 adoption. By integrating credit-card payments, AR.IO lowers friction for developers and businesses wanting censorship-resistant hosting. The true long-term play is embedding real-world payment rails into decentralized infrastructure—setting a precedent for other ledger-based services (e.g., Filecoin, IPFS pinning). If AR.IO can combine permanency with user-friendly billing, we may witness a tipping point in Web3’s shift from hobbyist experiments to enterprise solutions.
Conclusion
Today’s slate of headlines spans from consumer-facing esports innovations to deep industry self-reflection, from life-saving healthcare applications to sophisticated investment vehicles, and finally, critical infrastructure enabling mainstream onramps. Across every sector—gaming, finance, healthcare, asset management, and infrastructure—the recurring theme is bridging gaps:
-
On-chain & off-chain: through fiat onramps and traditional ETP listings
-
New chains & legacy systems: via interoperability and hybrid architectures
-
Speculation & real-world utility: with tangible ROI in healthcare and esports
For enthusiasts and professionals alike, the imperative is clear: focus on solutions that marry blockchain’s core benefits—transparency, security, decentralization—with seamless user experiences and regulatory alignment. Only then will we see blockchain and crypto transcend niche fervor to become indispensable pillars of tomorrow’s digital economy.
The post Blocks & Headlines: Today in Blockchain – May 7, 2025 | Coinbase, Riot Games, Curve DAO, Litecoin, AR.IO appeared first on News, Events, Advertising Options.
Blockchain
Colb Asset SA Raises $7.3 Million in Oversubscribed Round to Bring Pre-IPO Giants to Blockchain
Blockchain
Flipido Trading Center Launches ‘Flipido Learn’ Platform to Empower Crypto Investors Through Education
-
Blockchain6 days ago
HODL 2025: Blockchain’s Brightest Minds. All in Dubai
-
Blockchain Press Releases6 days agoInterlace Debuts at Token2049 to Accelerate Web2-Web3 Integration Across MENA
-
Blockchain Press Releases6 days agoFrom Exchange to Ecosystem Builder: MEXC Celebrates 7th Anniversary at TOKEN2049 Dubai with $300M Ecosystem Development Fund Launch
-
Blockchain7 days agoSkyCrest Capital Launches SkyAlpha X 2.0 AI System and Innovative SkyFund Protocol (SKF)
-
Blockchain Press Releases2 days agoHTX Premieres USD1 Stablecoin Globally, Partnering with World Liberty Financial to Forge a New Era of Decentralized Economy
-
Blockchain Press Releases6 days ago
Bybit and St. Paul American Scholars School Furthers Partnership Commitment in Bybit’s HQ Visit
-
Blockchain Press Releases2 days agoJuCoin made a global impact at TOKEN2049 Dubai, advancing its ecosystem with the “Peak Experience” vision and JuChain’s robust tech.
-
Blockchain5 days agoUnitedStaking.com Launches Advanced Crypto Staking Platform with Global Reach and Real-World Impact
